310 related articles for article (PubMed ID: 8394988)
1. Expression of mRNA for the serotonin 5-hydroxytryptamine1D beta receptor subtype in human and bovine cerebral arteries.
Hamel E; Fan E; Linville D; Ting V; Villemure JG; Chia LS
Mol Pharmacol; 1993 Aug; 44(2):242-6. PubMed ID: 8394988
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels.
Bouchelet I; Cohen Z; Case B; Séguéla P; Hamel E
Mol Pharmacol; 1996 Aug; 50(2):219-23. PubMed ID: 8700126
[TBL] [Abstract][Full Text] [Related]
3. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
[TBL] [Abstract][Full Text] [Related]
4. 5-HT receptors mediating external carotid vasoconstriction in vagosympathectomized dogs.
Villalón CM; Centurión D; Sánchez-López A; De Vries P; Saxena P
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1057-67. PubMed ID: 11216445
[TBL] [Abstract][Full Text] [Related]
5. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.
Bouchelet I; Case B; Olivier A; Hamel E
Br J Pharmacol; 2000 Feb; 129(3):501-8. PubMed ID: 10711348
[TBL] [Abstract][Full Text] [Related]
6. Evidence for 5-HT1D beta but not 5-HT1D alpha receptor subtype expression in canine large coronary arteries and saphenous vein.
Sgard F; Faure C; Graham D
Cardiovasc Res; 1996 May; 31(5):793-9. PubMed ID: 8763409
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ
J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression.
Verheggen R; Hundeshagen AG; Brown AM; Schindler M; Kaumann AJ
Br J Pharmacol; 1998 Aug; 124(7):1345-54. PubMed ID: 9723944
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein.
Cohen ML; Schenck K
J Pharmacol Exp Ther; 1999 Sep; 290(3):935-9. PubMed ID: 10454462
[TBL] [Abstract][Full Text] [Related]
10. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA
Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718
[TBL] [Abstract][Full Text] [Related]
11. Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect.
Edvinsson L; Uddman E; Wackenfors A; Davenport A; Longmore J; Malmsjö M
Clin Sci (Lond); 2005 Sep; 109(3):335-42. PubMed ID: 15853772
[TBL] [Abstract][Full Text] [Related]
12. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization.
Cohen Z; Bouchelet I; Olivier A; Villemure JG; Ball R; Stanimirovic DB; Hamel E
J Cereb Blood Flow Metab; 1999 Aug; 19(8):908-17. PubMed ID: 10458598
[TBL] [Abstract][Full Text] [Related]
13. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Monsma FJ; Shen Y; Ward RP; Hamblin MW; Sibley DR
Mol Pharmacol; 1993 Mar; 43(3):320-7. PubMed ID: 7680751
[TBL] [Abstract][Full Text] [Related]
14. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE
Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573
[TBL] [Abstract][Full Text] [Related]
15. Cloning and pharmacological characterization of a novel human 5-hydroxytryptamine1D receptor subtype.
Veldman SA; Bienkowski MJ
Mol Pharmacol; 1992 Sep; 42(3):439-44. PubMed ID: 1328844
[TBL] [Abstract][Full Text] [Related]
16. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
[TBL] [Abstract][Full Text] [Related]
17. Sumatriptan in the treatment of migraine.
Ferrari MD
Neurology; 1993 Jun; 43(6 Suppl 3):S43-7. PubMed ID: 8389011
[TBL] [Abstract][Full Text] [Related]
18. Developments in 5-hydroxytryptamine receptor pharmacology in migraine.
Peroutka SJ
Neurol Clin; 1990 Nov; 8(4):829-39. PubMed ID: 2259314
[TBL] [Abstract][Full Text] [Related]
19. Amplification of sumatriptan-induced contractions with phenylephrine, histamine and KCl in the isolated human mesenteric artery: in-vitro evidence for sumatriptan-induced mesenteric ischaemia.
Gul H; Yildiz O
Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):254-61. PubMed ID: 12172708
[TBL] [Abstract][Full Text] [Related]
20. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry.
Nilsson T; Longmore J; Shaw D; Olesen IJ; Edvinsson L
Br J Pharmacol; 1999 Nov; 128(6):1133-40. PubMed ID: 10578124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
